TianYu Bio-Technology Balance Sheet Health
Financial Health criteria checks 4/6
TianYu Bio-Technology has a total shareholder equity of CN¥873.3M and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 129.9%. Its total assets and total liabilities are CN¥3.3B and CN¥2.5B respectively.
Key information
129.9%
Debt to equity ratio
CN¥1.13b
Debt
Interest coverage ratio | n/a |
Cash | CN¥200.93m |
Equity | CN¥873.32m |
Total liabilities | CN¥2.48b |
Total assets | CN¥3.35b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603717's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 603717's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 603717's net debt to equity ratio (106.9%) is considered high.
Reducing Debt: 603717's debt to equity ratio has increased from 38.9% to 129.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 603717 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 603717 has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 5.2% each year.